4.7 Article

Exosome-based approaches in the management of Alzheimer?s disease

Related references

Note: Only part of the references are listed.
Editorial Material Cell Biology

Extracellular vesicles drive tau spreading in Alzheimer's disease

Zhi Ruan

NEURAL REGENERATION RESEARCH (2022)

Review Biochemistry & Molecular Biology

Diagnostic and therapeutic potential of exosomes in Alzheimer's disease

Tania Soares Martins et al.

Summary: Exosomes are small extracellular vesicles that can be used to unravel disease mechanisms or as a source of disease biomarkers. They play a significant role in neurodegenerative diseases, particularly Alzheimer's disease. Researchers are exploring the use of exosomes derived from biofluids for clinical practice in the near future.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Immunology

Milk exosomes: A biogenic nanocarrier for small molecules and macromolecules to combat cancer

Raghuram Kandimalla et al.

Summary: Exosomes are biogenic nanocarriers of endocytic origin found in biofluids like milk, with milk exosomes being a particularly promising source for drug delivery. They are being increasingly explored for delivering both small drug molecules and siRNA to combat cancer, thanks to their biocompatibility and unique properties. Various isolation techniques, physicochemical properties, biodistribution, and applications of milk exosomes in drug delivery were highlighted in this article.

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2021)

Article Medicine, Research & Experimental

Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease

Sanjay Arora et al.

Summary: This study demonstrated efficient brain-targeted delivery of ApoE2 gene therapy using surface-modified liposomes, with significantly higher ApoE2 expression in neurons and potential for effective AD treatment.

MOLECULAR PHARMACEUTICS (2021)

Article Clinical Neurology

Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons

Zhi Ruan et al.

Summary: This study comprehensively characterized the physicochemical structure and pathogenic function of extracellular vesicles derived from human brains in Alzheimer's disease, prodromal Alzheimer's disease, and non-demented control cases. It was found that extracellular vesicles from Alzheimer's disease cases had higher levels of tau oligomers and exhibited more efficient propagation and misfolding of tau, suggesting a novel mechanism for tau spread in the hippocampus.

BRAIN (2021)

Editorial Material Clinical Neurology

The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests

Emily A. Largent et al.

Summary: Emerging direct-to-consumer tests for Alzheimer's disease, which measure blood levels of phosphorylated tau protein, present both benefits and challenges in terms of diagnosis and treatment.

JAMA NEUROLOGY (2021)

Article Oncology

Exosome-mediated delivery of RNA and DNA for gene therapy

Radha Munagala et al.

Summary: The use of bovine colostrum exosomes and polyethyleneimine matrix for gene delivery shows promise in targeting KRAS and WT p53 for effective gene therapy, representing a novel platform for therapeutic nucleic acids delivery to treat human disease.

CANCER LETTERS (2021)

Review Biotechnology & Applied Microbiology

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges

Amanda Cano et al.

Summary: Increasing life expectancy has led to a rise in dementia cases, particularly Alzheimer's disease, which is expected to reach 131 million cases by 2050. The lack of effective treatments and late diagnosis hinder disease management, highlighting the urgent need for improved diagnostic tools and therapeutic approaches for AD. Nanomedicine-based technologies, including advanced nanoparticles, show promise in improving drug effectiveness and tracking disease progression.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Review Neurosciences

Relationship Between Amyloid-β Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease

Dong Wang et al.

Summary: Amyloid-beta is a significant factor in Alzheimer's disease, affecting the progression and prognosis. Its deposition damages the blood-brain barrier, while dysfunction of the barrier exacerbates Aβ accumulation. This review highlights the interactions and mechanisms between Aβ deposition and BBB damage in AD.

FRONTIERS IN CELLULAR NEUROSCIENCE (2021)

Review Biochemistry & Molecular Biology

Exosomal delivery of therapeutic modulators through the blood-brain barrier; promise and pitfalls

Morteza Heidarzadeh et al.

Summary: Current drug delivery strategies for neurological disorders face challenges due to the blood-brain barrier (BBB) limiting transport to the brain parenchyma. Stem cell byproducts such as exosomes are proposed as natural nano-drug carriers, but the intact BBB may hinder their delivery. Understanding the molecular mechanisms behind exosomal trafficking through the BBB remains unclear despite some preliminary studies showing potential.

CELL AND BIOSCIENCE (2021)

Review Neurosciences

The Emerging Role of Neural Cell-Derived Exosomes in Intercellular Communication in Health and Neurodegenerative Diseases

Luyao Huo et al.

Summary: Exosomes play a crucial role in intercellular communication in the central nervous system, regulating cellular function and contributing to both health and neurodegenerative diseases.

FRONTIERS IN NEUROSCIENCE (2021)

Article Multidisciplinary Sciences

The dichotomous role of extracellular vesicles in the central nervous system

David R. Graykowski et al.

iScience (2020)

Article Biochemistry & Molecular Biology

Neuroprotective effect of quercetin nanoparticles: A possible prophylactic and therapeutic role in alzheimer's disease

Rehab Ahmed Rifaai et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2020)

Review Neurosciences

A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity

Hossam Kadry et al.

FLUIDS AND BARRIERS OF THE CNS (2020)

Review Cell Biology

Dietary habits, lifestyle factors and neurodegenerative diseases

Aurel Popa-Wagner et al.

NEURAL REGENERATION RESEARCH (2020)

Article Multidisciplinary Sciences

Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition

Carine Z. J. Lim et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

BIN1 favors the spreading of Tau via extracellular vesicles

Andrea Crotti et al.

SCIENTIFIC REPORTS (2019)

Article Chemistry, Multidisciplinary

Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer's Disease

Shweta Kishor Sonawane et al.

ACS OMEGA (2019)

Review Chemistry, Multidisciplinary

Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics

Wei Tang et al.

CHEMICAL SOCIETY REVIEWS (2019)

Article Pharmacology & Pharmacy

PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization

Daniela E. Igartua et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Article Nanoscience & Nanotechnology

Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model

Dario Carradori et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)

Article Multidisciplinary Sciences

Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures

Andre M. Miranda et al.

NATURE COMMUNICATIONS (2018)

Review Neurosciences

Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers

Servio H. Ramirez et al.

FLUIDS AND BARRIERS OF THE CNS (2018)

Article Biochemistry & Molecular Biology

Amyloid precursor protein products concentrate in a subset of exosomes specifically endocytosed by neurons

Karine Laulagnier et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Article Nanoscience & Nanotechnology

Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer's disease treatment

Yung-Chih Kuo et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

Article Nanoscience & Nanotechnology

Neuroprotection against apoptosis of SK-N-MC cells using RMP-7-and lactoferrin-grafted liposomes carrying quercetin

Yung-Chih Kuo et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

Article Multidisciplinary Sciences

Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer

Sushrut Kamerkar et al.

NATURE (2017)

Review Pharmacology & Pharmacy

The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier

Junichi Matsumoto et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Article Pharmacology & Pharmacy

Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin

Farrukh Aqil et al.

AAPS JOURNAL (2017)

Review Biochemistry & Molecular Biology

Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases

Guohua Lou et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2017)

Article Oncology

Bovine milk-derived exosomes for drug delivery

Radha Munagala et al.

CANCER LETTERS (2016)

Article Biochemistry & Molecular Biology

Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease

Edward J. Goetzl et al.

FASEB JOURNAL (2016)

Article Biochemistry & Molecular Biology

Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner

Juan Carlos Polanco et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Nanoscience & Nanotechnology

Guidance of Magnetic Nanocontainers for Treating Alzheimer's Disease Using an Electromagnetic, Targeted Drug-Delivery Actuator

Ton Duc Do et al.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)

Review Medicine, Research & Experimental

Extracellular vesicles of the blood-brain barrier

Ibolya E. Andras et al.

TISSUE BARRIERS (2016)

Article Neurosciences

Depletion of microglia and inhibition of exosome synthesis halt tau propagation

Hirohide Asai et al.

NATURE NEUROSCIENCE (2015)

Article Biochemistry & Molecular Biology

A potential function for neuronal exosomes: Sequestering intracerebral amyloid-β peptide

Kohei Yuyama et al.

FEBS LETTERS (2015)

Review Biochemistry & Molecular Biology

Exosomes Derived from Mesenchymal Stem Cells

Bo Yu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Biochemistry & Molecular Biology

Decreased Amyloid-β Pathologies by Intracerebral Loading of Glycosphingolipid-enriched Exosomes in Alzheimer Model Mice

Kohei Yuyama et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Chemistry, Multidisciplinary

The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease

Chi Zhang et al.

JOURNAL OF CONTROLLED RELEASE (2014)

Article Neurosciences

Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics

Anuradha Kalani et al.

MOLECULAR NEUROBIOLOGY (2014)

Article Cell Biology

Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons

Mathilde Chivet et al.

JOURNAL OF EXTRACELLULAR VESICLES (2014)

Article Cell Biology

Dynamics of exosome internalization and trafficking

Tian Tian et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2013)

Article Biotechnology & Applied Microbiology

Grape Exosome-like Nanoparticles Induce Intestinal Stem Cells and Protect Mice From DSS-Induced Colitis

Songwen Ju et al.

MOLECULAR THERAPY (2013)

Review Biochemistry & Molecular Biology

Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease

Meng-Shan Tan et al.

TRENDS IN MOLECULAR MEDICINE (2013)

Article Neurosciences

Wnt Signalling is a Relevant Pathway Contributing to Amyloid Beta-Peptide-Mediated Neuropathology in Alzheimers Disease

Odete A.B. da Cruz e Silva et al.

CNS & Neurological Disorders-Drug Targets (2012)

Review Endocrinology & Metabolism

Drug transport across the blood-brain barrier

William M. Pardridge

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)

Article Nanoscience & Nanotechnology

Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer's disease amyloid protein

Kristen M. Jaruszewski et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)

Article Engineering, Biomedical

Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide

Spyridon Mourtas et al.

BIOMATERIALS (2011)

Article Chemistry, Medicinal

New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations

N. Basaran Mutlu et al.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2011)

Article Biotechnology & Applied Microbiology

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

Lydia Alvarez-Erviti et al.

NATURE BIOTECHNOLOGY (2011)

Article Clinical Neurology

Tau in Alzheimer Disease and Related Tauopathies

K. Iqbal et al.

CURRENT ALZHEIMER RESEARCH (2010)

Article Biochemistry & Molecular Biology

Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies

Valerie Vingtdeux et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Multidisciplinary Sciences

Alzheimer's disease β-amyloid peptides are released in association with exosomes

Lawrence Rajendran et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Biotechnology & Applied Microbiology

Drug and gene targeting to the brain with molecular Trojan horses

WM Pardridge

NATURE REVIEWS DRUG DISCOVERY (2002)